共 7 条
- [1] INHIBITION OF INTESTINAL EPITHELIAL CELL PYROPTOSIS AND ASSOCIATED MUCOSAL BARRIER DEFECTS IS A POTENTIAL THERAPEUTIC MECHANISM OF ACTION FOR MESALAMINE IN IBD[J]. GASTROENTEROLOGY, 2019, 156 (03) : S88 - S88Davis, Elisabeth M.Zhang, DiGlover, Sarah C.Stappenbeck, ThaddeusWang, ShanzhiLiu, Julia J.
- [2] INHIBITION OF INTESTINAL EPITHELIAL CELL PYROPTOSIS AND ASSOCIATED MUCOSAL BARRIER DEFECTS IS A POTENTIAL THERAPEUTIC MECHANISM OF ACTION FOR MESALAMINE IN IBD[J]. GASTROENTEROLOGY, 2019, 156 (06) : S627 - S627Davis, Elisabeth M.Zhang, DiGlover, Sarah C.Stappenbeck, Thaddeus S.Wang, ShanziLiu, Julia J.
- [3] Mucosal Microbiota that Breach the Intestinal Epithelial Barrier-A Step Towards Identifying Potential Pathogens in IBD[J]. INFLAMMATORY BOWEL DISEASES, 2016, 22 : S68 - S68Dheer, RishuDavies, JulieQuintero, Maria AlejandraSantaolalla, RebecaDeshpande, AmarKerman, DavidMcCauley, JacobAbreu, Maria
- [4] Novel therapeutic mechanism of mesalamine:: Protection against TNF-α induced opening of the intestinal epithelial tight-junction barrier[J]. GASTROENTEROLOGY, 2002, 122 (04) : A276 - A276Akotia, VHoa, NMa, TY
- [5] Alternative mechanisms of action of tacrolimus in IBD: Inhibition of intestinal epithelial cell- and NKT cell-activation[J]. GASTROENTEROLOGY, 2006, 130 (04) : A366 - A366van Dieren, Jolanda M.van der Woude, JannekeLambers, M. E.Kuipers, Ernst J.Nieuwenhuis, Edward E.
- [6] Induction of Mucosal Inflammation by Danger-Associated Molecular Patterns (DAMPs): Intestinal Epithelial Cell (IEC)-Derived IL-1α as a New Player in the Pathogenesis of IBD[J]. GASTROENTEROLOGY, 2011, 140 (05) : S635 - S635Scarpa, MelaniaSadler, Tammy M.Fiocchi, ClaudioStylianou, Eleni
- [7] ACTIVATION OF CD4 ASSOCIATED P561CK BY EPITHELIAL-CELLS FROM PATIENTS WITH IBD - A POTENTIAL MECHANISM FOR DEFECTIVE SUPPRESSOR-CELL GENERATION[J]. GASTROENTEROLOGY, 1995, 108 (04) : A863 - A863LIN, AYYIO, XYMAYER, L